NASET News Alert

New Treatment for Brittle Bone Disease Found

August 22, 2013

A new treatment for children with brittle bone disease has been developed by the University of Sheffield and Sheffield Children's Hospital. The study of the new treatment for children with the fragile bone disease Osteogenesis Imperfecta was published this week in The Lancet. This is the first study to clearly demonstrate that the use of the medicine risedronate can not only reduce the risk of fracture in children with brittle bones but also have rapid action -- the curves for fracture risk begin to diverge after only 6 weeks of treatment. To read more, click here

Back to NASET News Alert
lost password?